Sign in

CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company

aTYR PHARMA INC

Sign in to watch
Ticker
ATYR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
203435077
Phone
8587318389
Business address
10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
  1. PRE 14A Proxy Proxy Statement (Preliminary)
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. SC 13G/A Stake Amended Statement of Ownership
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market buy Chief Financial Officer bought 1,923 shares at $6.75 ($12,980)
  12. 4 Open-market buy President and CEO bought 5,000 shares at $6.76 ($33,807)
  13. 4 Open-market buy President and CEO bought 2,500 shares at $8.58 ($21,438)
  14. 10-Q Report Quarterly Report
  15. 8-K Event Exhibits
  16. SC 13G/A Stake Amended Statement of Ownership
  17. SC 13G Stake Amended Statement of Ownership
  18. 4 Open-market buy Director bought 250,000 shares at $8.00 ($2,000,000)
  19. SC 13G Stake Amended Statement of Ownership
  20. SC 13G Stake Amended Statement of Ownership

Page 12 of 38 · 755 filings